Levosimendan as a “Bridge to Optimization” in Patients with Advanced Heart Failure with Reduced Ejection—A Single-Center Study

Background: Patients with advanced heart failure with reduced ejection fraction often cannot tolerate target doses of guideline-directed medical therapy due to symptomatic hypotension, renal dysfunction, and associated electrolyte abnormalities. While levosimendan can facilitate the titration of β-b...

Descripción completa

Detalles Bibliográficos
Autores principales: Masarone, Daniele, Kittleson, Michelle M., Martucci, Maria L., Valente, Fabio, Gravino, Rita, Verrengia, Marina, Ammendola, Ernesto, Contaldi, Carla, Di Palma, Vito, Caiazzo, Angelo, Petraio, Andrea, Pollesello, Piero, Pacileo, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9317236/
https://www.ncbi.nlm.nih.gov/pubmed/35887992
http://dx.doi.org/10.3390/jcm11144227

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9317236/
https://www.ncbi.nlm.nih.gov/pubmed/35887992
http://dx.doi.org/10.3390/jcm11144227

Ejemplares similares